MedTwenty
Companies

Vertex Pharmaceuticals (Europe) Ltd

This profile is still being built. It is not yet listed in the company index.

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

Timeline

  1. 30 Oct 2026

    MHRA extends Casgevy approval to children aged five and over with sickle cell disease and β-thalassaemia

    Source: MHRA

MedTwenty coverage